HUM Humana Inc. Common Stock
NYSE · Health Care · Visualizza su SEC EDGAR ↗ chiudi Ott 2, 2026 10-K/10-Q Lug 29, 2026HUM Snapshot del titolo Prezzo, capitalizzazione di mercato, P/E, EPS, ROE, debito/capitale proprio, intervallo 52 settimane
HUM Grafico del prezzo delle azioni OHLCV giornaliero con indicatori tecnici — panoramica, zoom e personalizza la tua visualizzazione
La granularità delle barre si adatta al periodo selezionato — passa il mouse sul grafico per vedere apertura/massimo/minimo/chiusura di una barra.
| Data ex-dividendo | Split | Tipo |
|---|---|---|
| 01 Agosto 1991 | 3-for-2 | Avanti |
| 01 Febbraio 1984 | 6-for-5 | Avanti |
| 01 Febbraio 1983 | 4-for-3 | Avanti |
| 01 Febbraio 1982 | 3-for-2 | Avanti |
Informazioni su Humana Inc. Common Stock Panoramica della società da Wikipedia
Humana Inc. is an American for-profit health insurance company based in Louisville, Kentucky. In 2024, the company ranked 92 on the Fortune 500 list. It is the fourth largest health insurance provider in the U.S.
History
1961–1983: Nursing homes and hospitals
Lawyers David A. Jones Sr. and Wendell Cherry founded a nursing home company in 1961. The company, known in 1968 as Extendicare Inc., became the largest nursing home company in the United States. In 1972, Jones and Cherry sold the nursing home chain to purchase hospitals. Humana became one of the first two for-profit hospital ventures in the U.S. along with Hospital Corporation of America (HCA).
In 1974, the partners changed the corporate name to Humana Inc. It grew in the following years, both by business and in 1978 through the takeover of American Medicorp Inc., which doubled the company's size, and grew into the world's largest hospital company in the 1980s.
1984–present
As the American health care system changed in the 1980s, "one of its hospitals in Arizona lost a contract with the largest health-maintenance organization in the area [and] Humana created its own health insurance plan."
In 1993, Humana executives spun off hospital operations from health insurance operations to create Galen Health Care. The following year they sold the 73 hospitals of Galen Health Care Inc. to Nashville-based Columbia Hospital Corporation of America for $3.4 billion.
In 1998, one year after Jones had stepped aside as CEO, UnitedHealthcare made an unsuccessful attempt to acquire Humana. Humana pulled out of the acquisition after United stock dropped $2.9 billion in value.
In 2010, Humana returned to providing healthcare services when it bought Texas-based Concentra Inc., which owns urgent-care and physical therapy centers, for $790 million. They went on to sell Concentra again in 2015 for $1 billion.
In July 2015, Aetna announced that it would acquire Humana for $37 billion. However, the U.S. Department of Justice's Antitrust Division alleged the acquisition would be anticompetitive and sued to block the transaction. Following a trial, U.S. district judge John D. Bates of the United States District Court for the District of Columbia agreed and issued an injunction blocking the acquisition. In February 2017, Aetna and Humana cancelled a $34 billion merger agreement after judges ruled against the merger for a second time.
In July 2018, Humana joined two private equity firms in the acquisition of Kindred Healthcare. The deal provided Humana with a 40% stake in the company's home health, hospice and community care businesses, called "Kindred at Home," for approximately $800 million.
In 2021, Susan Diamond, formerly occupying an interim position, was announced to be the new permanent CFO.
In 2024 Humana announced that they would be leaving the Humana Building, which they had occupied since the 1980s, in order to cut costs. Humana said that it planned to consolidate its workforce in its Waterside-Clocktower campus.
In 2026 KFF reported that Humana was the second-largest parent organization for Medicare Advantage by overall enrollment, and that it had the largest growth in that sector that year.
Humana Military Healthcare Services
In 1993, Humana founded Humana Military Healthcare Services (HMHS) as a wholly owned subsidiary. They were awarded their first TRICARE contract in 1995, and began serving military beneficiaries in 1996.
In 2009, HMHS' contract with the military was awarded to United Military and Veterans Services, a subsidiary of UnitedHealth Group. HMHS protested that decision and the Government Accountability Office upheld the protest in late 2009.
Legal campaign against drug price fixing
Humana filed a lawsuit in August 2019, alleging that 37 defendants engaged in a “far-reaching conspiracy” to “blatantly fix the price” of generic drugs. This follows a similar smaller lawsuit from October 2018.
Controversy
In 1987, Humana sued NBC over a story line in the television medical drama St. Elsewhere in which the hospital was to be sold to a for-profit medical corporation and renamed "Ecumena", with subsequent changes to the hospital, both positive and negative, emanating from that change. The company claimed that the program infringed on the Humana trademark. Humana failed to block the airing of the show, but was successful at forcing NBC into showing a disclaimer at the beginning of the September 30 episode saying that the drama had no connection whatsoever with Humana.
On May 30, 1996, Linda Peeno, a physician who was contracted to work for Humana for nine months, testified before Congress as to the downside of managed care. Peeno said she was effectively rewarded by her employer for causing the death of a patient, because it saved the company a half-million dollars. Peeno stated that she felt the "managed care" model was inherently unethical.
In 1999, season one of Michael Moore's TV series The Awful Truth reported on Humana refusing to pay for a diabetic patient with pancreatic failure needing a transplant. The man's policy stated it covered all of his diabetes-related expenses, but another section of the policy stated that it did not cover organ transplants. Moore conducted a fake funeral on the front steps of the Humana building, and three days later Humana changed its policy and authorized the man's treatment.
Michael Moore's 2007 documentary Sicko used the video of Linda Peeno's testimony. On June 28, 2007, Humana declared that Peeno was never a Humana "associate" (permanent, full-time employee), but rather a "part-time contractor." Humana disputed portions of her Congressional testimony by saying that because the patient's healthcare plan did not cover heart transplants, denial of coverage was valid.
On September 21, 2009, the U.S. Dept. of Health and Human Services opened an investigation into Humana for sending flyers to Medicare recipients that the AARP characterized as deceptive. The mail was made to appear to contain official information about Medicare Advantage and prescription drug benefit information, but instead alleged that core Medicare benefits could be cut by the Obama administration's healthcare reform, a claim refuted by John Rother, AARP's executive vice president. Douglas Elmendorf, the head of the Congressional Budget Office (CBO), supported the claim that Medicare benefits could be cut, but his comments were in reference to just one of several congressional bills. CBO estimates of another healthcare reform bill found that changes to premiums would vary. The Centers for Medicare and Medicaid Services instructed Humana to cease all such mailings to Medicare plan members pending an investigation. HHS Secretary Kathleen Sebelius, in a letter to the insurance industry, threatened that bad actors may be excluded from new health insurance markets that were to open in 2014. Senate Republicans pointed out in a letter to Sebelius that a 1997 directive from the Centers for Medicare and Medicaid Services explicitly allowed HMOs to tell members about legislation and urge them to express opinions.
Fonte: Wikipedia (Inglese), CC BY-SA 4.0 · Vedi su Wikipedia ↗
Performance decennale Andamento di ricavi, utile netto, margini e EPS
Valutazione Rapporti P/E, P/S, P/B, EV/EBITDA — il titolo è costoso o economico?
| Metrica | Tendenza 5 anni | HUM | media 5 anni | Mediana dei peer | Verdetto |
|---|---|---|---|---|---|
| P/E (TTM) | 36.7media 5 anni ≈23.6 | ≈23.6 | 36.3 | Sopravvalutato | |
| P/S (TTM) | 0.5media 5 anni ≈0.7 | ≈0.7 | 0.7 | Sottovalutato | |
| P/B (MRQ) | 4.0media 5 anni ≈4.6 | ≈4.6 | 3.9 | Valore equo | |
| EV / EBITDA | 25.8media 5 anni ≈19.0 | ≈19.0 | 16.1 | Valore equo | |
| Prezzo / FCF (TTM) | 39.6media 5 anni ≈54.2 | ≈54.2 | · | · | |
| Prezzo / Flusso di cassa (TTM) | 30.4media 5 anni ≈29.3 | ≈29.3 | 15.6 | Sopravvalutato | |
| EV / Ricavi (TTM) | 0.4media 5 anni ≈0.6 | ≈0.6 | · | · | |
| EV / FCF (TTM) | 33.5media 5 anni ≈46.5 | ≈46.5 | · | · | |
| Prezzo / Valore contabile tangibile (MRQ) | 4.3media 5 anni ≈14.5 | ≈14.5 | · | · |
La mediana dei peer viene calcolata su base standardizzata per metrica e potrebbe non corrispondere sempre alla base TTM/MRQ mostrata per questo titolo.
Redditività Margini lordi, operativi e netti; ROE, ROA, ROIC
| Metrica | Tendenza 5 anni | HUM | media 5 anni | Mediana dei peer | Verdetto |
|---|---|---|---|---|---|
| Margine Operativo (TTM) | 1.9%media 5 anni ≈3.2% | ≈3.2% | 3.5% | Debole | |
| EBITDA Margin (Margine EBITDA) | 2.1%media 5 anni ≈3.2% | ≈3.2% | 3.7% | Debole | |
| Margine ante imposte (TTM) | 1.1%media 5 anni ≈2.7% | ≈2.7% | 2.8% | Debole | |
| Margine di Profitto Netto (TTM) | 0.88%media 5 anni ≈2.2% | ≈2.2% | 2.9% | Debole | |
| ROA (TTM) | 2.4%media 5 anni ≈4.9% | ≈4.9% | 3.0% | Debole | |
| ROE (TTM) | 6.8%media 5 anni ≈13.3% | ≈13.3% | 10.1% | Debole | |
| ROIC | 7.4%media 5 anni ≈9.7% | ≈9.7% | 8.0% | Debole |
Salute finanziaria Debito, liquidità, solvibilità — solidità del bilancio
| Metrica | Tendenza 5 anni | HUM | media 5 anni | Mediana dei peer | Verdetto |
|---|---|---|---|---|---|
| Debito / Patrimonio Netto (MRQ) | 0.6media 5 anni ≈0.7 | ≈0.7 | 0.7 | Basso indebitamento | |
| Rapporto corrente (MRQ) | 1.7media 5 anni ≈1.7 | ≈1.7 | 1.7 | Liquidità elevata | |
| Quick Ratio (MRQ) | 1.3media 5 anni ≈1.3 | ≈1.3 | 1.3 | In linea | |
| Debito a lungo termine / Patrimonio netto (MRQ) | 0.6media 5 anni ≈0.7 | ≈0.7 | 0.7 | Basso indebitamento |
Crescita Crescita di ricavi, EPS e utile netto: YoY, CAGR 3Y, CAGR 5Y
| Metrica | Tendenza 5 anni | HUM | media 5 anni | Mediana dei peer | Verdetto |
|---|---|---|---|---|---|
| Revenue YoY (Ricavi YoY) | 10.1%media 5 anni ≈11.0% | ≈11.0% | · | · | |
| Revenue CAGR 3Y (CAGR Ricavi 3Y) | 11.8%media 5 anni ≈11.8% | ≈11.8% | · | · | |
| Revenue CAGR 5Y (CAGR Ricavi 5Y) | 10.9% | · | · | · | |
| EPS YoY | -1.4%media 5 anni ≈-14.8% | ≈-14.8% | · | · | |
| Net Income YoY (Utile Netto YoY) | -1.6%media 5 anni ≈-16.3% | ≈-16.3% | · | · | |
| EPS CAGR 3Y (CAGR EPS 3 anni) | -23.6%media 5 anni ≈-18.4% | ≈-18.4% | · | · | |
| EPS CAGR 5Y (CAGR EPS 5 anni) | -17.2% | · | · | · | |
| Net Income CAGR 3Y (CAGR Utile Netto 3 anni) | -24.9%media 5 anni ≈-20.0% | ≈-20.0% | · | · | |
| Net Income CAGR 5Y (CAGR Utile Netto 5 anni) | -18.8% | · | · | · |
Efficienza del Capitale Rotazione delle attività, rotazione delle scorte, rotazione dei crediti
| Metrica | Tendenza 5 anni | HUM | media 5 anni | Mediana dei peer | Verdetto |
|---|---|---|---|---|---|
| Asset Turnover (Rotazione delle attività) | 2.7media 5 anni ≈2.4 | ≈2.4 | 2.4 | In linea | |
| Receivables Turnover (Rotazione dei crediti) | 43.4media 5 anni ≈52.0 | ≈52.0 | 16.3 | Di prim'ordine | |
| Revenue / Employee (Ricavi / Dipendente) | ≈$1.9M | · | · | · |
valore · ≈ media 5 anni · mediana del settore · giudizio rispetto alla mediana
Dividendi Rendimento, payout ratio, storico dividendi, CAGR 5Y
| Data ex-dividendo | Importo | Valuta | Rendimento |
|---|---|---|---|
| Giu 26, 2026 | $0,89 | USD | ≈0.92% |
| Mar 27, 2026 | $0,89 | USD | ≈2.1% |
| Dic 26, 2025 | $0,89 | USD | ≈1.4% |
| Set 26, 2025 | $0,89 | USD | ≈1.4% |
| Giu 27, 2025 | $0,89 | USD | ≈1.5% |
| Mar 28, 2025 | $0,89 | USD | ≈1.3% |
| Dic 31, 2024 | $0,89 | USD | ≈1.4% |
| Set 30, 2024 | $0,89 | USD | ≈1.1% |
| Giu 28, 2024 | $0,89 | USD | ≈0.95% |
| Mar 27, 2024 | $0,89 | USD | ≈1.0% |
| Dic 28, 2023 | $0,89 | USD | ≈0.78% |
| Set 28, 2023 | $0,89 | USD | ≈0.70% |
| Giu 29, 2023 | $0,89 | USD | ≈0.75% |
| Mar 30, 2023 | $0,89 | USD | ≈0.67% |
| Dic 29, 2022 | $0,79 | USD | ≈0.61% |
| Set 29, 2022 | $0,79 | USD | ≈0.62% |
| Giu 29, 2022 | $0,79 | USD | ≈0.64% |
| Mar 30, 2022 | $0,79 | USD | ≈0.66% |
| Dic 30, 2021 | $0,70 | USD | ≈0.60% |
| Set 29, 2021 | $0,70 | USD | ≈0.69% |
Cronologia utili EPS effettivo vs stima, surprise %, tasso di superamento, data prossimi utili
| Periodo | Rapporto | EPS Actual | EPS Stimato | Sorpresa |
|---|---|---|---|---|
| 30 Giugno 2026 | Lug 29, 2026 | $7.61 | $7.29 | 4.3% |
| 31 Marzo 2026 | $10.31 | $10.29 | 0.21% | |
| 31 Dicembre 2025 | $-3.96 | $-4.05 | 2.1% | |
| 30 Settembre 2025 | $3.24 | $2.85 | 13.8% | |
| 30 Giugno 2025 | $6.27 | $5.98 | 4.9% | |
| 31 Marzo 2025 | $11.58 | $10.17 | 13.9% |
Fondamentali Completi Tutte le metriche per anno — conto economico, stato patrimoniale, rendiconto finanziario
Conto Economico
| Metrica | Tendenza | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $129.66B | $117.76B | $106.37B | $92.87B | $83.06B | $77.16B | $64.89B | $56.91B | $53.77B | $54.38B | $54.29B | $48.50B | |
| SG&A Expense | $15.45B | $13.70B | $13.19B | $12.67B | $10.12B | $10.05B | $7.38B | $7.53B | $6.57B | $7.17B | $7.29B | $7.64B | |
| Operating Income | $2.70B | $2.56B | $4.01B | $3.80B | $3.15B | $4.99B | $3.19B | $3.10B | $4.26B | $1.74B | $2.35B | $2.36B | |
| Interest Expense | · | · | $493M | $401M | $326M | $283M | $242M | $218M | $242M | $189M | $186M | $192M | |
| Other Non-op | $-451M | $-181M | $-137M | $-68M | $532M | $-103M | $506M | $-33M | $0 | $0 | · | · | |
| Pretax Income | $1.44B | $1.62B | $3.33B | $3.57B | $3.42B | $4.67B | $3.47B | $2.07B | $4.02B | $1.55B | $2.43B | $2.17B | |
| Income Tax | $250M | $413M | $836M | $762M | $485M | $1.31B | $763M | $391M | $1.57B | $938M | $1.16B | $1.02B | |
| Net Income | $1.19B | $1.21B | $2.49B | $2.81B | $2.93B | $3.37B | $2.71B | $1.68B | $2.45B | $614M | $1.28B | $1.15B | |
| EPS (Basic) | $9.87 | $10.01 | $20.09 | $22.20 | $22.79 | $25.47 | $20.20 | $12.24 | $16.94 | $4.11 | $8.54 | $7.44 | |
| EPS (Diluted) | $9.84 | $9.98 | $20.00 | $22.08 | $22.67 | $25.31 | $20.10 | $12.16 | $16.81 | $4.07 | $8.44 | $7.36 | |
| Shares (Basic) | 120,454,000 | 120,571,000 | 123,866,000 | 126,419,000 | 128,688,000 | 132,199,000 | 134,055,000 | 137,486,000 | 144,493,000 | 149,375,000 | 149,455,000 | 154,187,000 | |
| Shares (Diluted) | 120,826,000 | 120,869,000 | 124,441,000 | 127,094,000 | 129,396,000 | 133,012,000 | 134,727,000 | 138,403,000 | 145,585,000 | 150,917,000 | 151,142,000 | 155,874,000 | |
| EBITDA | $2.70B | $2.56B | $4.01B | $3.80B | $3.15B | $4.99B | $3.19B | $3.10B | $4.26B | $1.74B | $2.35B | $2.36B |
Stato Patrimoniale
| Metrica | Tendenza | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $4.20B | $2.22B | $4.69B | $5.06B | $3.39B | $4.67B | $4.05B | $2.34B | $4.04B | $3.88B | $2.57B | $1.94B | |
| Short-term Investments | $15.70B | $18.21B | $16.63B | $13.88B | $13.19B | $12.55B | $10.97B | · | · | · | · | · | |
| Receivables | $3.27B | $2.70B | $2.04B | $1.67B | $1.81B | $1.14B | $1.06B | $1.01B | $854M | $1.28B | $1.16B | $1.05B | |
| Other Current Assets | $9.56B | $6.68B | $6.63B | $5.57B | $6.49B | $5.28B | $3.81B | $3.56B | $2.95B | $3.44B | $4.71B | $4.01B | |
| Current Assets | $32.73B | $29.82B | $29.99B | $26.18B | $24.89B | $23.64B | $19.89B | $16.95B | $17.40B | $16.19B | $15.71B | $15.54B | |
| PP&E (Net) | $2.23B | $2.53B | $3.03B | $3.22B | $3.07B | $2.37B | $1.96B | $1.74B | $1.58B | $1.50B | $1.38B | $1.23B | |
| PP&E (Gross) | $5.52B | $5.67B | $5.88B | $6.36B | $5.95B | $5.49B | $4.62B | $4.05B | $3.56B | $3.19B | $2.72B | $2.91B | |
| Accum. Depreciation | $3.29B | $3.14B | $2.85B | $3.14B | $2.87B | $3.12B | $2.66B | $2.31B | $1.98B | $1.69B | $1.34B | $1.68B | |
| Goodwill | $9.69B | $9.63B | $9.55B | $9.14B | $11.09B | $4.45B | $3.93B | $3.90B | $3.28B | $3.27B | $3.27B | $3.23B | |
| Intangibles | $1.13B | $1.44B | $1.69B | $1.76B | $2.64B | $329M | $177M | $245M | $226M | $280M | $357M | $440M | |
| Other Non-current Assets | $3.13B | $3.38B | $3.38B | $3.38B | $4.38B | $2.13B | $1.83B | $1.38B | $2.17B | $2.23B | $2.48B | $1.58B | |
| Total Assets | $48.91B | $46.48B | $47.06B | $43.05B | $44.36B | $34.97B | $29.07B | $25.41B | $27.18B | $25.40B | $24.68B | $23.53B | |
| Accounts Payable | $5.72B | $5.26B | $6.57B | $5.24B | $4.51B | $4.01B | $3.75B | $3.07B | $4.07B | $2.47B | $2.21B | $2.10B | |
| Short-term Debt | · | · | · | · | · | · | · | $1.69B | $150M | $300M | $299M | $0 | |
| Current Liabilities | $16.35B | $16.94B | $18.87B | $17.18B | $15.33B | $13.39B | $10.93B | $10.08B | $9.41B | $7.82B | $8.15B | $7.47B | |
| Capital Leases | $418M | $392M | $444M | $456M | $546M | $355M | $332M | · | · | · | · | · | |
| Other Non-current Liabilities | $2.46B | $1.95B | $1.66B | $1.47B | $2.38B | $1.79B | $1.14B | $581M | $237M | $263M | $235M | $236M | |
| Total Liabilities | $31.17B | $30.03B | $30.75B | $27.68B | $28.25B | $21.24B | $17.04B | $15.25B | $17.34B | $14.71B | $14.33B | $13.88B | |
| Total Debt | $12.37B | $11.14B | $10.21B | $9.03B | $10.54B | $6.06B | $4.97B | $6.07B | $4.92B | $4.09B | $4.12B | $3.83B | |
| Common Stock | $33M | $33M | $33M | $33M | $33M | $33M | $33M | $33M | $33M | $33M | $33M | $33M | |
| Retained Earnings | $29.07B | $28.32B | $27.54B | $25.49B | $23.09B | $20.52B | $17.48B | $15.07B | $13.67B | $11.45B | $11.02B | $9.92B | |
| Treasury Stock | $14.42B | $14.37B | $13.66B | $12.16B | $10.16B | $9.92B | $8.46B | $7.32B | $6.33B | $3.30B | $3.29B | $2.86B | |
| AOCI | $-633M | $-1.07B | $-999M | $-1.30B | $42M | $391M | $156M | $-159M | $19M | $-66M | $58M | $223M | |
| Stockholders' Equity | $17.66B | $16.38B | $16.26B | $15.31B | $16.08B | $13.73B | $12.04B | $10.16B | $9.84B | $10.69B | $10.35B | $9.65B | |
| Liabilities + Equity | $48.91B | $46.48B | $47.06B | $43.05B | $44.36B | $34.97B | $29.07B | $25.41B | $27.18B | $25.40B | $24.68B | $23.53B | |
| Shares Outstanding | 198,719,000 | 198,719,000 | 198,690,000 | 198,667,000 | 198,649,000 | 198,649,000 | 198,630,000 | · | · | · | · | · |
Flusso di cassa
| Metrica | Tendenza | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $698M | $839M | $779M | $709M | $596M | · | · | $444M | $410M | $388M | $354M | $328M | |
| Stock-based Comp | $241M | $207M | $175M | $216M | $180M | $181M | $163M | $137M | $157M | $115M | $109M | $98M | |
| Deferred Tax | $75M | $-192M | $-164M | $-100M | $15M | $195M | $162M | $194M | $132M | $-71M | $-2M | $-64M | |
| Amort. of Intangibles | $51M | $60M | $67M | $81M | $65M | $88M | $70M | $90M | $75M | $77M | $93M | $121M | |
| Restructuring | · | · | · | · | · | · | $47M | · | $148M | · | · | · | |
| Operating Cash Flow | $921M | $2.97B | $3.98B | $4.59B | $2.26B | $5.64B | $5.28B | $2.17B | $4.05B | $1.94B | $868M | $1.62B | |
| CapEx | $546M | $575M | $1.00B | $1.14B | $1.34B | $964M | $736M | $612M | $524M | $527M | $523M | $528M | |
| Investing Cash Flow | $2.27B | $-2.95B | $-3.49B | $-1.01B | $-6.56B | $-3.06B | $-1.28B | $-3.09B | $-2.94B | $-1.36B | $320M | $-63M | |
| Net Debt Issued | · | · | · | · | · | · | $-400M | $0 | $-800M | $0 | $0 | $-500M | |
| Stock Repurchased | $151M | $817M | $1.57B | $2.10B | $79M | $1.82B | $1.07B | $1.09B | $3.37B | $104M | $385M | $872M | |
| Net Stock Activity | $-151M | $-817M | $-1.57B | $-2.10B | $-79M | $-1.82B | $-1.07B | $-1.09B | $-3.37B | $-104M | $-385M | $-872M | |
| Dividends Paid | $430M | $431M | $431M | $392M | $354M | $323M | $291M | $265M | $220M | $177M | $172M | $172M | |
| Financing Cash Flow | $-1.22B | $-2.49B | $-856M | $-1.91B | $3.02B | $-1.96B | $-2.29B | $-785M | $-945M | $732M | $-552M | $-758M | |
| Net Change in Cash | $1.98B | $-2.47B | $-367M | $1.67B | $-1.28B | $619M | $1.71B | $-1.70B | $165M | $1.31B | $636M | $797M | |
| Taxes Paid | · | $570M | $997M | $758M | $227M | $1.13B | $518M | $631M | $1.50B | $916M | $1.18B | $1.03B | |
| Free Cash Flow | $375M | $2.39B | $2.98B | $3.47B | $946M | $4.67B | $4.55B | $1.56B | $3.52B | $1.41B | $345M | $1.09B | |
| Levered FCF | · | · | $2.61B | $3.15B | $666M | $4.47B | $4.36B | $1.38B | $3.38B | $1.33B | $247M | $989M |
Redditività
| Metrica | Tendenza | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Margin | 2.1% | 2.2% | 3.8% | 4.1% | 3.8% | 6.5% | 4.9% | 5.5% | 7.9% | 3.2% | 4.3% | 4.9% | |
| Net Margin | 0.92% | 1.0% | 2.3% | 3.0% | 3.5% | 4.4% | 4.2% | 3.0% | 4.5% | 1.1% | 2.4% | 2.4% | |
| Pretax Margin | 1.1% | 1.5% | 3.1% | 3.8% | 4.1% | 6.1% | 5.3% | 3.6% | 7.5% | 2.9% | 4.5% | 4.5% | |
| EBITDA Margin | 2.1% | 2.2% | 3.8% | 4.1% | 3.8% | 6.5% | 4.9% | 5.5% | 7.9% | 3.2% | 4.3% | 4.9% | |
| ROA | 2.5% | 2.6% | 5.5% | 6.4% | 7.4% | 10.5% | 9.9% | 6.4% | 9.3% | 2.5% | 5.3% | 5.2% | |
| ROE | 7.0% | 7.4% | 15.8% | 18.2% | 18.1% | 22.8% | 22.9% | 16.2% | 23.3% | 5.8% | 12.8% | 12.1% | |
| ROIC | 7.4% | 7.1% | 11.3% | 12.3% | 10.1% | 18.1% | 14.6% | 15.5% | 17.6% | 4.7% | 8.5% | 9.3% |
Liquidità e Solvibilità
| Metrica | Tendenza | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 2.0 | 1.8 | 1.6 | 1.5 | 1.6 | 1.8 | 1.8 | 1.7 | 1.9 | 2.1 | 1.9 | 2.0 | |
| Quick Ratio | 1.4 | 1.4 | 1.2 | 1.2 | 1.2 | 1.4 | 0.5 | 0.3 | 0.5 | 0.7 | 0.5 | 0.4 | |
| Debt / Equity | 0.7 | 0.7 | 0.6 | 0.6 | 0.7 | 0.4 | 0.4 | 0.6 | 0.5 | 0.4 | 0.4 | 0.4 | |
| LT Debt / Equity | 0.7 | 0.7 | 0.6 | 0.6 | 0.7 | 0.4 | 0.4 | 0.4 | 0.5 | 0.4 | 0.4 | 0.4 | |
| Interest Coverage | · | · | 8.1 | 9.5 | 9.7 | 17.6 | 13.2 | 14.2 | 17.6 | 9.2 | 12.6 | 12.3 |
Efficienza
| Metrica | Tendenza | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 2.7 | 2.5 | 2.4 | 2.1 | 2.1 | 2.4 | 2.4 | 2.2 | 2.0 | 2.2 | 2.3 | 2.2 | |
| Receivables Turnover | 43.4 | 49.7 | 57.4 | 53.3 | 56.3 | 70.3 | 62.7 | 60.9 | 50.4 | 44.6 | 49.0 | 45.8 |
Per Azione
| Metrica | Tendenza | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Book Value / Share | $88.85 | $82.40 | $81.85 | $77.07 | · | · | · | · | · | · | · | · | |
| Revenue / Share | $1073.15 | $974.29 | $854.81 | $730.72 | $641.94 | $580.06 | $481.63 | $411.20 | $369.32 | $360.32 | $359.19 | $311.15 | |
| Cash Flow / Share | $7.62 | $24.54 | $31.99 | $36.09 | $17.48 | $42.39 | $39.22 | $15.70 | $27.83 | $12.83 | $5.74 | $10.38 | |
| Cash / Share | $21.14 | $11.18 | $23.62 | $25.47 | · | · | · | · | · | · | · | · | |
| Dividend / Share | · | · | · | · | · | · | · | · | · | $1.16 | $1.15 | $1.11 | |
| Dividend Paid / Share | $3.54 | $3.54 | $3.44 | $3.06 | $2.73 | $2.43 | $2.15 | $1.90 | $1.49 | $1.16 | $1.14 | $1.10 | |
| EPS (TTM) | $9.84 | $9.98 | $20.00 | $22.08 | $22.67 | $25.31 | $20.10 | $12.16 | $16.81 | $4.07 | $8.44 | $7.36 |
Tassi di Crescita
| Metrica | Tendenza | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY | 10.1% | 10.7% | 14.5% | 11.8% | 7.7% | · | · | · | · | · | · | · | |
| Revenue CAGR 3Y | 11.8% | 12.3% | 11.3% | · | · | · | · | · | · | · | · | · | |
| Revenue CAGR 5Y | 10.9% | · | · | · | · | · | · | · | · | · | · | · | |
| EPS YoY | -1.4% | -50.1% | -9.4% | -2.6% | -10.4% | · | · | · | · | · | · | · | |
| EPS CAGR 3Y | -23.6% | -23.9% | -7.5% | · | · | · | · | · | · | · | · | · | |
| EPS CAGR 5Y | -17.2% | · | · | · | · | · | · | · | · | · | · | · | |
| Net Income YoY | -1.6% | -51.5% | -11.3% | -4.3% | -12.9% | · | · | · | · | · | · | · | |
| Net Income CAGR 3Y | -24.9% | -25.6% | -9.6% | · | · | · | · | · | · | · | · | · | |
| Net Income CAGR 5Y | -18.8% | · | · | · | · | · | · | · | · | · | · | · | |
| Dividends Paid CAGR 5Y | 5.9% | · | · | · | · | · | · | · | · | · | · | · |
Valutazione (TTM)
| Metrica | Tendenza | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $129.66B | $117.76B | $106.37B | $92.87B | $83.06B | $77.16B | $64.89B | $56.91B | $53.77B | $54.38B | $54.29B | $48.50B | |
| Net Income TTM | $1.19B | $1.21B | $2.49B | $2.81B | $2.93B | $3.37B | $2.71B | $1.68B | $2.45B | $614M | $1.28B | $1.15B | |
| Market Cap | $50.90B | $50.42B | $90.96B | $101.76B | · | · | · | · | · | · | · | · | |
| Enterprise Value | $43.36B | $41.13B | $79.86B | $91.85B | · | · | · | · | · | · | · | · | |
| P/E | 26.0 | 25.4 | 22.9 | 23.2 | 20.5 | 16.2 | 18.2 | 23.6 | 14.8 | 50.1 | 21.2 | 19.5 | |
| P/S | 0.4 | 0.4 | 0.9 | 1.1 | · | · | · | · | · | · | · | · | |
| P/B | 2.9 | 3.1 | 5.6 | 6.6 | · | · | · | · | · | · | · | · | |
| P / Tangible Book | 7.4 | 9.5 | 18.1 | 23.1 | · | · | · | · | · | · | · | · | |
| P / Cash Flow | 55.3 | 17.0 | 22.8 | 22.2 | · | · | · | · | · | · | · | · | |
| P / FCF | 135.7 | 21.1 | 30.6 | 29.3 | · | · | · | · | · | · | · | · | |
| EV / EBITDA | 16.0 | 16.1 | 19.9 | 24.2 | · | · | · | · | · | · | · | · | |
| EV / FCF | 115.6 | 17.2 | 26.8 | 26.5 | · | · | · | · | · | · | · | · | |
| EV / Revenue | 0.3 | 0.3 | 0.8 | 1.0 | · | · | · | · | · | · | · | · | |
| Dividend Yield | 0.84% | 0.85% | 0.47% | 0.39% | · | · | · | · | · | · | · | · | |
| Earnings Yield | 3.8% | 3.9% | 4.4% | 4.3% | 4.9% | 6.2% | 5.5% | 4.2% | 6.8% | 2.0% | 4.7% | 5.1% | |
| Payout Ratio | 36.2% | 35.7% | 17.3% | 14.0% | 12.1% | 9.6% | 10.8% | 15.8% | 9.0% | 28.8% | 13.5% | 15.0% | |
| Annual Payout | $430M | $431M | $431M | $392M | $354M | $323M | $291M | $265M | $220M | $177M | $172M | $172M |
Conto Economico
| Metrica | Tendenza | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $40.87B | $39.65B | $32.52B | $32.65B | $32.39B | $32.11B | $29.21B | $29.40B | $29.54B | $29.61B | $26.46B | $26.42B | $26.75B | $26.74B | $22.44B | $22.80B | |
| SG&A Expense | $3.98B | $4.02B | $4.44B | $4.08B | $3.55B | $3.38B | $4.17B | $3.34B | $3.15B | $3.04B | $3.83B | $3.27B | $3.11B | $2.98B | $3.55B | $3.06B | |
| Operating Income | $1.36B | $1.75B | $-808M | $400M | $1.10B | $2.01B | $-543M | $728M | $1.14B | $1.24B | $-348M | $1.21B | $1.44B | $1.72B | $124M | $1.17B | |
| Interest Expense | · | · | · | · | · | · | · | · | · | $159M | · | $114M | $120M | $113M | · | $102M | |
| Other Non-op | $-211M | $34M | $-53M | $-35M | $-200M | $-163M | $-155M | $92M | $-55M | $-63M | $-97M | $6M | $-54M | $8M | $-84M | $-13M | |
| Pretax Income | $952M | $1.59B | $-1.13B | $134M | $741M | $1.69B | $-963M | $651M | $918M | $1.01B | $-610M | $1.09B | $1.25B | $1.60B | $-72M | $1.30B | |
| Income Tax | $238M | $395M | $-249M | $-86M | $179M | $406M | $-216M | $155M | $223M | $251M | $-75M | $256M | $296M | $359M | $-58M | $107M | |
| Net Income | $694M | $1.19B | $-796M | $195M | $545M | $1.24B | $-693M | $480M | $679M | $741M | $-541M | $832M | $959M | $1.24B | $-15M | $1.20B | |
| EPS (Basic) | $5.78 | $9.85 | $-6.58 | $1.62 | $4.52 | $10.31 | $-5.74 | $3.99 | $5.63 | $6.13 | $-4.26 | $6.74 | $7.70 | $9.91 | $-0.07 | $9.45 | |
| EPS (Diluted) | $5.73 | $9.83 | $-6.59 | $1.62 | $4.51 | $10.30 | $-5.73 | $3.98 | $5.62 | $6.11 | $-4.24 | $6.71 | $7.66 | $9.87 | $-0.08 | $9.39 | |
| Shares (Basic) | 120,066,000 | 120,332,000 | · | 120,273,000 | 120,539,000 | 120,666,000 | · | 120,405,000 | 120,445,000 | 120,978,000 | · | 123,426,000 | 124,574,000 | 125,005,000 | · | 126,572,000 | |
| Shares (Diluted) | 121,135,000 | 120,652,000 | · | 120,745,000 | 120,745,000 | 120,844,000 | · | 120,764,000 | 120,665,000 | 121,268,000 | · | 123,983,000 | 125,109,000 | 125,564,000 | · | 127,356,000 | |
| EBITDA | $1.36B | $1.75B | · | $400M | $1.10B | $2.01B | · | $728M | $1.14B | $1.24B | · | $1.21B | $1.44B | $1.72B | · | $1.17B |
Stato Patrimoniale
| Metrica | Tendenza | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $6.89B | $4.95B | $4.20B | $5.39B | $4.04B | $4.25B | $2.22B | $5.12B | $5.50B | $5.91B | · | $15.15B | $16.21B | $13.73B | · | $13.56B | |
| Short-term Investments | $16.98B | $17.01B | $15.70B | $16.74B | $17.67B | $17.89B | $18.21B | $19.03B | $17.42B | $16.70B | · | $15.14B | $15.25B | $14.93B | · | $13.12B | |
| Receivables | $5.70B | $5.22B | $3.27B | $2.68B | $4.50B | $4.46B | $2.70B | $2.14B | $4.09B | $3.92B | · | $1.82B | $1.43B | $3.11B | · | $1.61B | |
| Other Current Assets | $10.52B | $10.90B | $9.56B | $7.94B | $7.40B | $7.83B | $6.68B | $6.63B | $5.84B | $6.26B | · | $6.14B | $5.87B | $5.76B | · | $5.42B | |
| Current Assets | $40.09B | $38.08B | $32.73B | $32.75B | $33.62B | $34.42B | $29.82B | $32.93B | $32.86B | $32.80B | · | $38.25B | $38.76B | $37.53B | · | $33.71B | |
| PP&E (Net) | $2.10B | $2.17B | $2.23B | $2.27B | $2.36B | $2.43B | $2.53B | $2.69B | $2.82B | $2.98B | · | $3.34B | $3.31B | $3.23B | · | $3.22B | |
| PP&E (Gross) | · | · | $5.52B | · | · | · | $5.67B | · | · | · | · | · | · | · | · | · | |
| Accum. Depreciation | · | · | $3.29B | · | · | · | $3.14B | · | · | · | · | · | · | · | · | · | |
| Goodwill | $10.48B | $10.49B | $9.69B | $9.62B | $9.63B | $9.63B | $9.63B | $9.59B | $9.57B | $9.56B | $9.55B | $9.54B | $9.54B | $9.32B | $9.14B | $9.10B | |
| Intangibles | $1.18B | $1.19B | $1.13B | $1.23B | $1.38B | $1.43B | $1.44B | $1.65B | $1.66B | $1.68B | · | $1.76B | $1.78B | $1.75B | · | $1.80B | |
| Other Non-current Assets | $3.25B | $3.28B | $3.13B | $4.02B | $3.69B | $3.38B | $3.38B | $3.67B | $3.72B | $3.64B | · | $3.64B | $3.73B | $3.58B | · | $3.63B | |
| Total Assets | $57.20B | $55.28B | $48.91B | $49.72B | $50.36B | $50.93B | $46.48B | $50.01B | $50.09B | $50.09B | · | $55.91B | $56.45B | $54.78B | · | $50.77B | |
| Accounts Payable | $7.26B | $6.53B | $5.72B | $5.52B | $5.59B | $5.38B | $5.26B | $5.92B | $6.53B | $6.50B | · | $7.60B | $8.12B | $7.43B | · | $6.77B | |
| Current Liabilities | $23.01B | $21.51B | $16.35B | $16.18B | $17.22B | $18.04B | $16.94B | $18.73B | $19.79B | $19.69B | · | $27.82B | $28.28B | $26.94B | · | $25.05B | |
| Capital Leases | · | · | $418M | · | · | · | $392M | · | · | · | · | · | · | · | · | · | |
| Other Non-current Liabilities | $2.93B | $2.85B | $2.46B | $2.35B | $2.26B | $2.34B | $1.95B | $1.77B | $1.83B | $1.83B | · | $1.59B | $1.56B | $1.46B | · | $1.60B | |
| Total Liabilities | $37.92B | $36.63B | $31.17B | $31.14B | $32.06B | $33.11B | $30.03B | $32.38B | $33.37B | $33.91B | · | $38.90B | $39.56B | $38.14B | · | $34.45B | |
| Total Debt | $11.98B | $12.27B | · | $12.61B | $12.59B | $12.73B | · | $11.89B | $11.75B | $12.39B | · | $9.48B | $9.72B | $9.74B | · | $7.80B | |
| Common Stock | $33M | $33M | $33M | $33M | $33M | $33M | $33M | $33M | $33M | $33M | · | $33M | $33M | $33M | · | $33M | |
| Retained Earnings | $30.74B | $30.15B | $29.07B | $29.98B | $29.89B | $29.45B | $28.32B | $29.12B | $28.75B | $28.17B | · | $28.19B | $27.47B | $26.62B | · | $25.61B | |
| Treasury Stock | $14.51B | $14.52B | $14.42B | $14.46B | $14.46B | $14.36B | $14.37B | $14.40B | $14.40B | $14.36B | · | $13.13B | $12.75B | $12.22B | · | $11.15B | |
| AOCI | $-751M | $-731M | $-633M | $-666M | $-783M | $-868M | $-1.07B | $-653M | $-1.12B | $-1.09B | · | $-1.50B | $-1.23B | $-1.11B | · | $-1.47B | |
| Stockholders' Equity | $19.21B | $18.58B | $17.66B | $18.52B | $18.23B | $17.75B | $16.38B | $17.57B | $16.67B | $16.13B | · | $16.95B | $16.83B | $16.58B | · | $16.32B | |
| Liabilities + Equity | $57.20B | $55.28B | $48.91B | $49.72B | $50.36B | $50.93B | $46.48B | $50.01B | $50.09B | $50.09B | · | $55.91B | $56.45B | $54.78B | · | $50.77B | |
| Shares Outstanding | 198,720,000 | 198,720,000 | 198,719,000 | 198,719,000 | 198,719,000 | 198,719,000 | 198,719,000 | 198,719,000 | 198,719,000 | 198,691,000 | 198,690,000 | 198,690,000 | 198,690,000 | 198,667,000 | 198,667,000 | 198,667,000 |
Flusso di cassa
| Metrica | Tendenza | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $159M | $163M | $164M | $173M | $178M | $183M | $208M | $210M | $212M | $209M | $201M | $201M | $191M | $186M | · | · | |
| Stock-based Comp | $65M | $51M | $48M | $83M | $61M | $49M | $54M | $53M | $55M | $45M | $33M | $53M | $51M | $38M | $43M | $80M | |
| Deferred Tax | · | · | · | · | · | · | · | · | · | · | $-164M | $0 | · | · | $-67M | $-200M | |
| Amort. of Intangibles | $8M | $11M | $8M | $13M | $15M | $15M | $14M | $15M | $15M | $16M | $16M | $17M | $16M | $18M | $20M | $25M | |
| Operating Cash Flow | $1.97B | $1.25B | $-1.65B | $971M | $1.27B | $331M | $-528M | $1.86B | $1.21B | $423M | $-7.13B | $1.25B | $3.18B | $6.69B | $-5.13B | $8.45B | |
| CapEx | $132M | $121M | $202M | $135M | $114M | $95M | $154M | $130M | $114M | $177M | $283M | $234M | $264M | $223M | $275M | $288M | |
| Investing Cash Flow | $-273M | $-2.55B | $632M | $980M | $347M | $314M | $-63M | $-1.47B | $-1.00B | $-414M | $-882M | $-585M | $-733M | $-1.29B | $-1.01B | $1.68B | |
| Debt Issued | $0 | $990M | · | · | $0 | $1.48B | · | · | · | · | · | · | · | · | · | · | |
| Net Debt Issued | · | $980M | · | · | · | · | · | · | · | · | · | · | · | · | · | · | |
| Stock Repurchased | $1M | $107M | $42M | $0 | $100M | $9M | $49M | $2M | $49M | $717M | $571M | $379M | $529M | $94M | $1.06B | $4M | |
| Net Stock Activity | · | $-107M | · | · | · | $-9M | · | · | · | $-717M | · | · | · | $-94M | · | · | |
| Dividends Paid | $107M | $107M | $109M | $107M | $106M | $108M | $108M | $107M | $107M | $109M | $111M | $109M | $111M | $100M | $101M | $100M | |
| Financing Cash Flow | $249M | $2.05B | $-168M | $-603M | $-1.83B | $1.38B | $-2.30B | $-770M | $-620M | $1.21B | $-2.44B | $-1.73B | $36M | $3.28B | $-2.36B | $-1.79B | |
| Net Change in Cash | $1.94B | $751M | $-1.19B | $1.35B | $-210M | $2.03B | $-2.90B | $-385M | $-409M | $1.22B | $-10.45B | $-1.07B | $2.48B | $8.67B | $-8.50B | $8.34B | |
| Taxes Paid | $148M | $-7M | · | $122M | $41M | $-12M | · | $208M | $361M | $1M | · | $276M | $675M | $6M | $7M | $378M | |
| Free Cash Flow | · | $1.13B | · | · | · | $236M | · | · | · | $246M | · | · | · | $6.46B | · | · | |
| Levered FCF | · | · | · | · | · | · | · | · | · | $127M | · | · | · | $6.38B | · | · |
Redditività
| Metrica | Tendenza | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Margin | 3.3% | 4.4% | · | 1.2% | 3.4% | 6.3% | · | 2.5% | 3.9% | 4.2% | · | 4.6% | 5.4% | 6.4% | · | 5.1% | |
| Net Margin | 1.7% | 3.0% | · | 0.60% | 1.7% | 3.9% | · | 1.6% | 2.3% | 2.5% | · | 3.1% | 3.6% | 4.6% | · | 5.2% | |
| Pretax Margin | 2.3% | 4.0% | · | 0.41% | 2.3% | 5.3% | · | 2.2% | 3.0% | 3.3% | · | 4.1% | 4.7% | 6.0% | · | 5.7% | |
| EBITDA Margin | 3.3% | 4.4% | · | 1.2% | 3.4% | 6.3% | · | 2.5% | 3.9% | 4.2% | · | 4.6% | 5.4% | 6.4% | · | 5.1% | |
| ROA | 1.3% | 2.2% | · | 0.39% | 1.1% | 2.5% | · | 0.91% | 1.3% | 1.4% | · | 1.6% | 1.9% | 2.5% | · | 2.5% | |
| ROE | 3.7% | 6.5% | · | 1.1% | 3.1% | 7.3% | · | 2.8% | 4.0% | 4.5% | · | 5.0% | 5.9% | 7.8% | · | 7.3% | |
| ROIC | 3.3% | 4.3% | · | 2.1% | 2.7% | 5.0% | · | 1.9% | 3.0% | 3.2% | · | 3.5% | 4.1% | 5.1% | · | 4.5% |
Liquidità e Solvibilità
| Metrica | Tendenza | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 1.7 | 1.8 | · | 2.0 | 2.0 | 1.9 | · | 1.8 | 1.7 | 1.7 | · | 1.4 | 1.4 | 1.4 | · | 1.3 | |
| Quick Ratio | 1.3 | 1.3 | · | 1.5 | 1.5 | 1.5 | · | 1.4 | 1.4 | 1.3 | · | 1.2 | 1.2 | 1.2 | · | 1.1 | |
| Debt / Equity | 0.6 | 0.7 | · | 0.7 | 0.7 | 0.7 | · | 0.7 | 0.7 | 0.8 | · | 0.6 | 0.6 | 0.6 | · | 0.5 | |
| LT Debt / Equity | 0.6 | 0.7 | · | 0.7 | 0.7 | 0.7 | · | 0.7 | 0.7 | 0.8 | · | 0.6 | 0.6 | 0.6 | · | 0.5 | |
| Interest Coverage | · | · | · | · | · | · | · | · | · | 7.8 | · | 10.6 | 12.0 | 15.2 | · | 11.5 |
Efficienza
| Metrica | Tendenza | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.8 | 0.7 | · | 0.7 | 0.6 | 0.6 | · | 0.6 | 0.6 | 0.6 | · | 0.5 | 0.5 | 0.5 | · | 0.5 | |
| Receivables Turnover | 8.0 | 8.2 | · | 13.5 | 7.5 | 7.7 | · | 14.8 | 10.7 | 8.4 | · | 15.4 | 11.1 | 8.5 | · | 13.1 |
Per Azione
| Metrica | Tendenza | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Book Value / Share | $96.68 | $93.50 | · | $93.21 | $91.76 | $89.33 | · | $88.39 | $83.89 | $81.18 | · | $85.30 | $84.72 | $83.44 | · | $82.13 | |
| Revenue / Share | $337.37 | $328.61 | · | $270.40 | $268.23 | $265.73 | · | $243.43 | $244.81 | $244.18 | · | $213.12 | $213.79 | $212.98 | · | $179.02 | |
| Cash Flow / Share | · | $10.39 | · | · | · | $2.74 | · | · | · | $3.49 | · | · | · | $53.26 | · | · | |
| Cash / Share | $34.69 | $24.91 | · | $27.11 | $20.33 | $21.39 | · | $25.74 | $27.68 | $29.74 | · | $76.24 | $81.60 | $69.14 | · | $68.24 | |
| Dividend / Share | $0.89 | $0.89 | $0.89 | · | · | $0.89 | $0.89 | · | · | · | · | · | · | · | · | · | |
| Dividend Paid / Share | $0.89 | $0.89 | $0.89 | $0.89 | $0.89 | $0.89 | $0.89 | $0.89 | $0.89 | $0.89 | · | · | · | · | · | · | |
| EPS (TTM) | $10.59 | $9.37 | · | $10.70 | $13.06 | $14.17 | · | $11.47 | $14.20 | $16.24 | · | $24.16 | $26.84 | $24.66 | · | $22.05 |
Valutazione (TTM)
| Metrica | Tendenza | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $145.68B | $137.20B | · | $126.36B | $123.11B | $120.26B | · | $115.01B | $112.04B | $109.24B | · | $102.35B | $98.73B | $95.64B | · | $91.48B | |
| Net Income TTM | $1.28B | $1.13B | · | $1.29B | $1.58B | $1.71B | · | $1.36B | $1.71B | $1.99B | · | $3.02B | $3.38B | $3.12B | · | $2.81B | |
| Market Cap | $78.94B | $34.46B | · | $51.70B | $48.58B | $52.58B | · | $62.94B | $74.25B | $68.89B | · | $96.67B | $88.84B | $96.44B | · | $96.39B | |
| Enterprise Value | $67.04B | $24.77B | · | $42.18B | $39.46B | $43.17B | · | $50.68B | $63.07B | $58.67B | · | $75.86B | $67.10B | $77.52B | · | $77.51B | |
| P/E | 37.5 | 18.5 | · | 24.3 | 18.7 | 18.7 | · | 27.6 | 26.3 | 21.3 | · | 20.1 | 16.7 | 19.7 | · | 22.0 | |
| P/S | 0.5 | 0.3 | · | 0.4 | 0.4 | 0.4 | · | 0.5 | 0.7 | 0.6 | · | 0.9 | 0.9 | 1.0 | · | 1.1 | |
| P/B | 4.1 | 1.9 | · | 2.8 | 2.7 | 3.0 | · | 3.6 | 4.5 | 4.3 | · | 5.7 | 5.3 | 5.8 | · | 5.9 | |
| P / Tangible Book | 10.5 | 5.0 | · | 6.7 | 6.7 | 7.9 | · | 10.0 | 13.6 | 14.1 | · | 17.1 | 16.1 | 17.5 | · | 17.8 | |
| P / Cash Flow | · | 27.5 | · | · | · | 158.9 | · | · | · | 162.9 | · | · | · | 14.4 | · | · | |
| EV / Revenue | 0.5 | 0.2 | · | 0.3 | 0.3 | 0.4 | · | 0.4 | 0.6 | 0.5 | · | 0.7 | 0.7 | 0.8 | · | 0.8 | |
| Dividend Yield | 0.54% | 1.2% | · | 0.83% | 0.88% | 0.82% | · | 0.69% | 0.59% | 0.64% | · | 0.44% | 0.46% | 0.42% | · | 0.40% | |
| Earnings Yield | 2.7% | 5.4% | · | 4.1% | 5.3% | 5.4% | · | 3.6% | 3.8% | 4.7% | · | 5.0% | 6.0% | 5.1% | · | 4.5% | |
| Payout Ratio | · | 9.0% | · | · | · | 8.7% | · | · | · | 14.7% | · | · | · | 8.1% | · | · | |
| Annual Payout | $430M | $429M | · | $429M | $429M | $430M | · | $434M | $436M | $440M | · | $421M | $412M | $401M | · | $382M |
Periodo più recente a sinistra · valori nulli mostrati come ·
Bilanci Conto economico, stato patrimoniale, flusso di cassa — annuale, ultimi 5 anni
| Metrica | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Ricavi | $129.66B | $117.76B | $106.37B | $92.87B | $83.06B |
| Margine Operativo % | 2.1% | 2.2% | 3.8% | 4.1% | 3.8% |
| Utile netto | $1.19B | $1.21B | $2.49B | $2.81B | $2.93B |
| EPS Diluito | $9.84 | $9.98 | $20.00 | $22.08 | $22.67 |
| Metrica | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Debito / Patrimonio Netto | 0.7 | 0.7 | 0.6 | 0.6 | 0.7 |
| Rapporto corrente | 2.0 | 1.8 | 1.6 | 1.5 | 1.6 |
| Quick Ratio | 1.4 | 1.4 | 1.2 | 1.2 | 1.2 |
| Metrica | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Flusso di cassa libero | $375M | $2.39B | $2.98B | $3.47B | $946M |
Proprietari istituzionali (13F) 1.038 filer · $52.7B totale · Aggiornato al 30 Settembre 2026
Istituzioni che segnalano il possesso di questo titolo nel loro Modulo SEC 13F trimestrale. Solo posizioni lunghe; un singolo depositante può apparire due volte per diverse gambe di opzioni. Grandi posizioni put/call contrapposte riflettono tipicamente market-making o inventario coperto, non convinzione direzionale.
| Nuove posizioni | Posizioni chiuse | Aumentato | Diminuito | Variazione netta delle azioni |
|---|---|---|---|---|
| 248 (+126 vs trimestre precedente) | 85 (-76 vs trimestre precedente) | 325 (+68 vs trimestre precedente) | 288 (-56 vs trimestre precedente) | +3.9M |
Confrontato con Q1 2026. Le dichiarazioni SEC Form 13F sono dovute entro 45 giorni dalla fine del trimestre più un breve margine per i dichiaranti in ritardo — i trimestri ancora all'interno di questa finestra vengono saltati a favore della coppia più recente completamente riportata.
| Istituzione | Valore | Azioni | % di 13F tracciati | Tipo |
|---|---|---|---|---|
| Dodge & Cox | $4.345.737.744 | 10.940.380 | 8,25% | Azioni |
| BlackRock, Inc. | $4.138.159.785 | 10.417.803 | 7,85% | Azioni |
| VANGUARD GROUP INC | $3.652.890.202 | 14.261.860 | 6,93% | Azioni |
| VANGUARD CAPITAL MANAGEMENT LLC | $3.115.642.737 | 7.843.620 | 5,91% | Azioni |
| VANGUARD PORTFOLIO MANAGEMENT LLC | $2.311.405.702 | 5.818.956 | 4,39% | Azioni |
| STATE STREET CORP | $2.172.441.313 | 5.457.072 | 4,12% | Azioni |
| PZENA INVESTMENT MANAGEMENT LLC | $1.749.013.682 | 4.403.136 | 3,32% | Azioni |
| MASSACHUSETTS FINANCIAL SERVICES CO /MA/ | $1.664.784.292 | 3.578.245 | 3,16% | Azioni |
| EAGLE CAPITAL MANAGEMENT LLC | $1.528.010.749 | 3.846.762 | 2,90% | Azioni |
| Sessa Capital IM, L.P. | $1.480.732.883 | 3.727.740 | 2,81% | Azioni |
| GEODE CAPITAL MANAGEMENT, LLC | $1.337.386.742 | 3.369.757 | 2,54% | Azioni |
| JPMORGAN CHASE & CO | $1.257.951.102 | 3.234.637 | 2,39% | Azioni |
| FMR LLC | $1.157.405.236 | 2.913.763 | 2,20% | Azioni |
| Capital International Investors | $950.462.637 | 2.392.826 | 1,80% | Azioni |
| GOLDMAN SACHS GROUP INC | $913.562.254 | 2.299.889 | 1,73% | Azioni |
| NAYA CAPITAL MANAGEMENT UK LTD | $728.407.339 | 1.833.763 | 1,38% | Azioni |
| NORGES BANK | $694.505.009 | 1.748.414 | 1,32% | Azioni |
| Invesco Ltd. | $587.403.999 | 1.478.788 | 1,11% | Azioni |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | $544.521.489 | 1.370.831 | 1,03% | Azioni |
| MORGAN STANLEY | $535.876.914 | 1.349.066 | 1,02% | Azioni |
| DIMENSIONAL FUND ADVISORS LP | $445.839.059 | 1.122.669 | 0,85% | Azioni |
| Capital Research Global Investors | $443.462.035 | 1.116.990 | 0,84% | Azioni |
| NORTHERN TRUST CORP | $442.978.948 | 1.115.198 | 0,84% | Azioni |
| Slate Path Capital LP | $428.969.795 | 1.079.930 | 0,81% | Azioni |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $423.436.520 | 1.066.000 | 0,80% | Opzione Put |
| Capital World Investors | $406.119.738 | 1.022.425 | 0,77% | Azioni |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $399.841.652 | 1.006.600 | 0,76% | Opzione Call |
| Newport Trust Company, LLC | $384.768.345 | 968.653 | 0,73% | Azioni |
| CITADEL ADVISORS LLC | $363.376.856 | 914.800 | 0,69% | Opzione Call |
| HOTCHKIS & WILEY CAPITAL MANAGEMENT LLC | $348.908.912 | 878.377 | 0,66% | Azioni |
| Legal & General Group Plc | $329.760.125 | 830.170 | 0,63% | Azioni |
| BARROW HANLEY MEWHINNEY & STRAUSS LLC | $314.921.577 | 792.814 | 0,60% | Azioni |
| CITADEL ADVISORS LLC | $310.904.094 | 782.700 | 0,59% | Opzione Put |
| Allianz Asset Management GmbH | $307.098.329 | 773.119 | 0,58% | Azioni |
| WELLINGTON MANAGEMENT GROUP LLP | $304.014.312 | 765.355 | 0,58% | Azioni |
| BANK OF AMERICA CORP /DE/ | $279.490.113 | 703.615 | 0,53% | Azioni |
| VANGUARD FIDUCIARY TRUST CO | $267.791.027 | 674.163 | 0,51% | Azioni |
| Maple Rock Capital Partners Inc. | $249.553.862 | 628.251 | 0,47% | Azioni |
| Diamond Hill Capital Management, LLC (Investment Advisor) | $245.555.446 | 618.185 | 0,47% | Azioni |
| Bank of New York Mellon Corp | $238.144.113 | 599.527 | 0,45% | Azioni |
| GOLDMAN SACHS GROUP INC | $232.333.978 | 584.900 | 0,44% | Opzione Call |
| MARSHALL WACE, LLP | $216.873.381 | 545.978 | 0,41% | Azioni |
| UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC | $189.649.820 | 1.093.776 | 0,36% | Azioni |
| CITADEL ADVISORS LLC | $178.360.519 | 449.022 | 0,34% | Azioni |
| High Ground Investment Management LLP | $177.941.848 | 447.968 | 0,34% | Azioni |
| 1832 Asset Management L.P. | $176.401.430 | 444.090 | 0,33% | Azioni |
| BCV Asset Management Inc. | $173.695.656 | 445.719 | 0,33% | Azioni |
| Nuveen, LLC | $167.646.743 | 422.051 | 0,32% | Azioni |
| Holocene Advisors, LP | $165.040.541 | 415.489 | 0,31% | Azioni |
| DEUTSCHE BANK AG\ | $163.345.207 | 411.221 | 0,31% | Azioni |
Attivisti e proprietari del 5%+ 1 partecipazione
Investitori che hanno depositato SEC Schedule 13D — proprietà effettiva superiore al 5% con l'intento di influenzare l'emittente (partecipazioni attiviste, campagne per il consiglio di amministrazione, M&A). Ogni riga mostra lo stato più recente noto della posizione di quel depositante.
| Depositante | Depositato | Partecipazione | Stato | Scopo | Deposito |
|---|---|---|---|---|---|
| David A. Jones ×2 depositi | 12 Novembre 2003 | · | Deposito iniziale | · | SEC |
Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.
Insider aziendali 79 insider · 48 dirigenti · 29 direttori
| Insider | Ruolo | Ultima attività | Azioni possedute | Acquisti 12m | Vendite 12m | Netto 12m |
|---|---|---|---|---|---|---|
| James A. Rechtin | President & CEO | 01 Maggio 2026 A | 63.938 | 0 | 0 | $0 |
| Bruce D Broussard | Chief Executive Officer | 21 Febbraio 2024 A | 110.130 | 0 | 0 | $0 |
| Celeste Mellet | Chief Financial Officer | 01 Maggio 2026 A | 39.637 | 0 | 0 | $0 |
| Susan M Diamond | Chief Financial Officer | 31 Dicembre 2024 J | 20.165 | 0 | 0 | $0 |
| Brian A Kane | Chief Financial Officer | 22 Febbraio 2021 A | 24.342 | 0 | 0 | $0 |
| Steven E Mcculley | Interim CFO & Treasurer | 09 Maggio 2014 G | 14.916 | 0 | 0 | $0 |
| Aaron Martin | President, Medicare Advantage | 01 Maggio 2026 A | 25.237 | 0 | 0 | $0 |
| David Dintenfass | President, Enterprise Growth | 01 Maggio 2026 A | 25.407 | 0 | 0 | $0 |
| Sanjay K Shetty | President, CenterWell | 01 Maggio 2026 A | 22.088 | 1 | 0 | $150.012 |
| George Renaudin II | President, Insurance | 31 Marzo 2026 J | 16.075 | 0 | 0 | $0 |
| M.D. Andrew C. Agwunobi, | Seg. President, Home Solutions | 24 Febbraio 2023 A | 182 | 0 | 0 | $0 |
| Timothy Alan Wheatley | Segment President, Retail | 15 Dicembre 2022 M | 3.983 | 0 | 0 | $0 |
| Joseph William Jasser | Seg. President, Care Delivery | 15 Dicembre 2017 M | 222 | 0 | 0 | $0 |
| Thomas J Liston | President - Retail Segment | 18 Febbraio 2014 A | 105.443 | 0 | 0 | $0 |
| James E Murray | EVP & COO | 31 Marzo 2017 J | 34.668 | 0 | 0 | $0 |
| Shantanu Nundy | Chief Medical Officer | 01 Settembre 2026 A | 2.549 | 0 | 0 | $0 |
| Japan Mehta | Chief Information Officer | 01 Maggio 2026 A | 17.176 | 0 | 0 | $0 |
| Michelle A. O'Hara | Chief Human Resources Officer | 01 Maggio 2026 A | 20.026 | 0 | 0 | $0 |
| Joseph C Ventura | Chief Legal Officer | 01 Maggio 2026 A | 27.405 | 0 | 0 | $0 |
| John-Paul W. Felter | SVP, Chief Accting Off & Cont. | 24 Febbraio 2026 F | 7.484 | 0 | 0 | $0 |
| Vishal Agrawal | Chief Strat & Corp Dev Officer | 24 Febbraio 2025 A | 16.717 | 0 | 0 | $0 |
| Timothy S. Huval | Chief Administrative Officer | 31 Dicembre 2024 G | 7.111 | 0 | 0 | $0 |
| Samir Deshpande | Chief Information Officer | 15 Dicembre 2024 M | 14.015 | 0 | 0 | $0 |
| William Kevin Fleming | Chief Corporate Aff. Officer | 21 Febbraio 2024 A | 11.723 | 0 | 0 | $0 |
| Susan D. Schick | Seg Pres. Grp. & Military Bus. | 24 Febbraio 2023 F | 3.687 | 0 | 0 | $0 |
| William H Shrank | Chief Medical Officer | 01 Maggio 2022 M | 4.294 | 0 | 0 | $0 |
| Cynthia H Zipperle | SVP, Chief Acct Officer & Cont | 22 Marzo 2022 J | 5.723 | 0 | 0 | $0 |
| Heather Cox | Chief Dig Health & Analyt Off. | 25 Febbraio 2022 F | 6.014 | 0 | 0 | $0 |
| Christopher H. Hunter | Seg Pres. Gr. & Military Bus. | 16 Marzo 2021 G | 8.168 | 0 | 0 | $0 |
| Elizabeth D Bierbower | Strategic Advisor | 18 Dicembre 2019 M | 18.092 | 0 | 0 | $0 |
| Brian P. Leclaire | Strategic Advisor | 15 Dicembre 2019 M | 6.339 | 0 | 0 | $0 |
| Jody L Bilney | Chief Consumer Officer | 25 Febbraio 2019 A | 9.774 | 0 | 0 | $0 |
| Roy A Beveridge, | Chief Medical Officer | 19 Febbraio 2019 M | 10.791 | 0 | 0 | $0 |
| Todoroff M Christopher | Chief Legal Officer | 15 Dicembre 2018 M | 11.136 | 0 | 0 | $0 |
| Heidi S Margulis | Chief Corp. Affairs Officer | 15 Dicembre 2018 M | 6.476 | 0 | 0 | $0 |
| Christopher E Kay | SVP & Chief Innovation Officer | 17 Marzo 2017 M | 4.361 | 0 | 0 | $0 |
| Tim S Mcclain | Group Pres, Govt & Other Busin | 18 Febbraio 2014 A | 1.101 | 0 | 0 | $0 |
| Bruce D Perkins | Sgmt Pres, Healthcare Services | 18 Febbraio 2014 A | 15.946 | 0 | 0 | $0 |
| Paul B. K. Kusserow | Sr VP & Ch Strat Dev Officer | 24 Giugno 2013 M | 19.347 | 0 | 0 | $0 |
| HATHCOCK BONNIE C | Sr VP & Chief Human Res. Off | 24 Dicembre 2012 G | 2.287 | 0 | 0 | $0 |
| Venkata R Madabhushi | SVP & Chief Innov & Mrkting Of | 28 Aprile 2012 F | 11.946 | 0 | 0 | $0 |
| GOODMAN BRUCE J | Sr. VP | 23 Febbraio 2012 A | 23.280 | 0 | 0 | $0 |
| Jonathan T Lord MD | Sr VP & Chief Innovation Off. | 04 Febbraio 2009 I | 0 | 0 | 0 | $0 |
| Arthur P Hipwell | Senior Vice President | 27 Marzo 2008 J | 302 | 0 | 0 | $0 |
| Kathleen Pellegrino | VP and Acting General Counsel | 25 Febbraio 2008 F | 13.836 | 0 | 0 | $0 |
| Steven O Moya | Sr. VP-Chief Marketing Officer | 31 Dicembre 2007 I | 0 | 0 | 0 | $0 |
| John M Bertko | Vice President & Chief Actuary | 23 Febbraio 2007 M | 57.548 | 0 | 0 | $0 |
| Eugene R Shields | Senior Vice President-Gov Prgm | 06 Gennaio 2005 M | 0 | 0 | 0 | $0 |
| Kurt J Hilzinger | Direttore | 30 Settembre 2026 A | 19.448 | 0 | 0 | $0 |
| Paul John Smith | Direttore | 01 Agosto 2026 A | 544 | 0 | 0 | $0 |
| Robert Stuart Field | Direttore | 01 Maggio 2026 A | 852 | 0 | 0 | $0 |
| Jorge S. Mesquita | Direttore | 02 Gennaio 2026 A | 4.127 | 0 | 0 | $0 |
| Frank A Damelio | Direttore | 02 Gennaio 2026 A | 20.634 | 0 | 0 | $0 |
| Raquel C. Bono | Direttore | 31 Dicembre 2025 A | 397 | 0 | 0 | $0 |
| Wayne A.I. Frederick | Direttore | 31 Dicembre 2025 A | 440 | 0 | 0 | $0 |
| Marcy S Klevorn | Direttore | 31 Dicembre 2025 A | 436 | 0 | 0 | $0 |
| John W Garratt | Direttore | 31 Dicembre 2025 A | 1.685 | 0 | 0 | $0 |
| David T Feinberg | Direttore | 31 Dicembre 2025 A | 1.207 | 0 | 0 | $0 |
| Karen Katz | Direttore | 31 Dicembre 2025 A | 590 | 0 | 0 | $0 |
| Brad D Smith | Direttore | 31 Dicembre 2024 A | 1.169 | 0 | 0 | $0 |
| William J. Mcdonald | Direttore | 02 Gennaio 2024 A | 2.276 | 0 | 0 | $0 |
| JONES DAVID A JR/KY | Direttore | 28 Febbraio 2023 G | 32.440 | 0 | 0 | $0 |
| OBRIEN JAMES J /KY | Direttore | 03 Gennaio 2023 A | 1.794 | 0 | 0 | $0 |
| Marissa T Peterson | Direttore | 03 Gennaio 2022 A | 2.044 | 0 | 0 | $0 |
| Frank Bisignano | Direttore | 04 Gennaio 2021 A | 2.727 | 0 | 0 | $0 |
| Webster Roy Dunbar | Direttore | 31 Dicembre 2019 A | 2.880 | 0 | 0 | $0 |
| Karen B Desalvo | Direttore | 02 Gennaio 2019 A | 634 | 0 | 0 | $0 |
| David Nash | Direttore | 02 Gennaio 2019 A | 112 | 0 | 0 | $0 |
| William Mitchell | Direttore | 31 Dicembre 2018 A | 688 | 0 | 0 | $0 |
| Michael B Mccallister | Direttore | 31 Dicembre 2013 M | 113.885 | 0 | 0 | $0 |
| Ann W Reynolds | Direttore | 15 Maggio 2011 M | 39.727 | 0 | 0 | $0 |
| James O Robbins | Direttore | 03 Gennaio 2007 A | · | 0 | 0 | $0 |
| HALL JOHN R /KY | Direttore | 03 Gennaio 2006 A | 22.423 | 0 | 0 | $0 |
| JONES DAVID A SR/KY | Direttore | 05 Aprile 2005 G | 4.777.524 | 0 | 0 | $0 |
| Michael E Gellert | Direttore | 03 Gennaio 2005 A | 60.237 | 0 | 0 | $0 |
| Irwin Lerner | Direttore | 02 Gennaio 2004 A | 30.637 | 0 | 0 | $0 |
| Frederick John Crawford | · | 01 Agosto 2026 A | 544 | 0 | 0 | $0 |
| Gordon Smith | · | 31 Dicembre 2025 A | 765 | 0 | 0 | $0 |
| James H Bloem | · | 07 Novembre 2013 M | 30.326 | 0 | 0 | $0 |
Insider dai depositi SEC Modulo 3/4/5; netto = solo acquisti/vendite di mercato
Proprietà ETF Posseduti da 143 ETF
Il peso riflette solo le partecipazioni azionarie dirette (N-PORT); fondi a leva o basati su derivati possono detenere ulteriore esposizione swap non mostrata.
| Fondo | Peso | Unità | Aggiornato al | Fonte |
|---|---|---|---|---|
| IHF · iShares Trust | 4,63% | 151.582 SH | 11 Settembre 2026 | Giornaliero |
| FMTM · EA Series Trust | 3,07% | 21.303 NS | 31 Luglio 2026 | N-PORT |
| TGLB · T. Rowe Price Exchange-Traded Funds… | 2,57% | 1.854 NS | 31 Luglio 2026 | N-PORT |
| RPV · Invesco Exchange-Traded Fund Trust | 2,35% | 103.450 SH | 02 Ottobre 2026 | Giornaliero |
| SRHQ · Elevation Series Trust | 2,31% | 13.473 NS | 31 Luglio 2026 | N-PORT |
| EPMV · Harbor ETF Trust | 1,75% | 225 NS | 31 Luglio 2026 | N-PORT |
| CVAR · ETF Opportunities Trust | 1,71% | 2.014 NS | 31 Luglio 2026 | N-PORT |
| RSPH · Invesco Exchange-Traded Fund Trust | 1,57% | 35.951 SH | 02 Ottobre 2026 | Giornaliero |
| NUMV · Nushares ETF Trust | 1,39% | 16.939 NS | 31 Luglio 2026 | N-PORT |
| JDOC · J.P. Morgan Exchange-Traded Fund Tr… | 1,16% | 290 NS | 31 Luglio 2026 | N-PORT |
| FVAL · FIDELITY COVINGTON TRUST | 0,88% | 32.276 NS | 31 Luglio 2026 | N-PORT |
| VOE · VANGUARD INDEX FUNDS | 0,82% | 771.237 SH | 19 Agosto 2026 | Giornaliero |
| IYH · iShares Trust | 0,78% | 70.303 SH | 11 Settembre 2026 | Giornaliero |
| JOET · Virtus ETF Trust II | 0,74% | 4.940 NS | 31 Luglio 2026 | N-PORT |
| PALC · Pacer Funds Trust | 0,74% | 4.248 NS | 31 Luglio 2026 | N-PORT |
| RWL · Invesco Exchange-Traded Fund Trust … | 0,71% | 181.374 SH | 02 Ottobre 2026 | Giornaliero |
| VHT · VANGUARD WORLD FUND | 0,70% | 360.880 SH | 19 Agosto 2026 | Giornaliero |
| PDP · Invesco Exchange-Traded Fund Trust | 0,70% | 27.208 SH | 02 Ottobre 2026 | Giornaliero |
| FHLC · FIDELITY COVINGTON TRUST | 0,63% | 57.108 NS | 31 Luglio 2026 | N-PORT |
| IXJ · iShares Trust | 0,61% | 63.215 SH | 11 Settembre 2026 | Giornaliero |
| CURE · Direxion Shares ETF Trust | 0,50% | 2.362 NS | 31 Luglio 2026 | N-PORT |
| IWS · iShares Trust | 0,47% | 179.478 SH | 11 Settembre 2026 | Giornaliero |
| VO · VANGUARD INDEX FUNDS | 0,46% | 2.601.869 SH | 19 Agosto 2026 | Giornaliero |
| IMCV · iShares Trust | 0,40% | 11.586 SH | 11 Settembre 2026 | Giornaliero |
| MTUM · iShares Trust | 0,37% | 227.558 SH | 11 Settembre 2026 | Giornaliero |
| IWR · iShares Trust | 0,35% | 492.212 SH | 11 Settembre 2026 | Giornaliero |
| PRF · Invesco Exchange-Traded Fund Trust | 0,34% | 88.063 SH | 02 Ottobre 2026 | Giornaliero |
| IMCB · iShares Trust | 0,34% | 14.123 SH | 11 Settembre 2026 | Giornaliero |
| VRP · Invesco Exchange-Traded Fund Trust … | 0,33% | 10.420.000 | 02 Ottobre 2026 | Giornaliero |
| FFLC · FIDELITY COVINGTON TRUST | 0,32% | 10.722 NS | 31 Luglio 2026 | N-PORT |
| IUS · Invesco Exchange-Traded Self-Indexe… | 0,32% | 8.116 SH | 02 Ottobre 2026 | Giornaliero |
| IMCG · iShares Trust | 0,27% | 27.157 SH | 11 Settembre 2026 | Giornaliero |
| XOEF · iShares Trust | 0,27% | 151 SH | 11 Settembre 2026 | Giornaliero |
| VLUE · iShares Trust | 0,26% | 62.879 SH | 11 Settembre 2026 | Giornaliero |
| PFIG · Invesco Exchange-Traded Fund Trust … | 0,25% | 320.000 | 02 Ottobre 2026 | Giornaliero |
| SIZE · iShares Trust | 0,24% | 2.599 SH | 11 Settembre 2026 | Giornaliero |
| BSCS · Invesco Exchange-Traded Self-Indexe… | 0,23% | 8.027.000 | 02 Ottobre 2026 | Giornaliero |
| ROUS · Lattice Strategies Trust | 0,23% | 4.462 NS | 31 Luglio 2026 | N-PORT |
| BSCR · Invesco Exchange-Traded Self-Indexe… | 0,22% | 9.983.000 | 02 Ottobre 2026 | Giornaliero |
| EUSA · iShares, Inc. | 0,22% | 10.324 SH | 11 Settembre 2026 | Giornaliero |
| HELO · J.P. Morgan Exchange-Traded Fund Tr… | 0,21% | 26.395 NS | 31 Luglio 2026 | N-PORT |
| CATH · Global X Funds | 0,21% | 7.419 NS | 31 Luglio 2026 | N-PORT |
| VYM · VANGUARD WHITEHALL FUNDS | 0,20% | 479.438 SH | 19 Agosto 2026 | Giornaliero |
| RSP · Invesco Exchange-Traded Fund Trust | 0,19% | 487.833 SH | 02 Ottobre 2026 | Giornaliero |
| EVUS · iShares Trust | 0,19% | 1.842 SH | 11 Settembre 2026 | Giornaliero |
| USXF · iShares Trust | 0,19% | 7.125 SH | 11 Settembre 2026 | Giornaliero |
| ESMV · iShares Trust | 0,19% | 37 SH | 11 Settembre 2026 | Giornaliero |
| SUSA · iShares Trust | 0,19% | 19.078 SH | 11 Settembre 2026 | Giornaliero |
| ACVF · ETF Opportunities Trust | 0,19% | 790 NS | 31 Luglio 2026 | N-PORT |
| VTV · VANGUARD INDEX FUNDS | 0,18% | 1.140.642 SH | 19 Agosto 2026 | Giornaliero |
| DFLV · Dimensional ETF Trust | 0,18% | 32.943 NS | 31 Luglio 2026 | N-PORT |
| JVAL · J.P. Morgan Exchange-Traded Fund Tr… | 0,17% | 3.921 NS | 31 Luglio 2026 | N-PORT |
| VFVA · VANGUARD WELLINGTON FUND | 0,17% | 3.648 SH | 19 Agosto 2026 | Giornaliero |
| DFSU · Dimensional ETF Trust | 0,17% | 10.472 NS | 31 Luglio 2026 | N-PORT |
| IVE · iShares Trust | 0,16% | 200.080 SH | 11 Settembre 2026 | Giornaliero |
| VOOV · VANGUARD ADMIRAL FUNDS | 0,16% | 27.648 SH | 19 Agosto 2026 | Giornaliero |
| IUSV · iShares Trust | 0,15% | 104.740 SH | 11 Settembre 2026 | Giornaliero |
| VEGN · ETF Series Solutions | 0,15% | 709 NS | 31 Luglio 2026 | N-PORT |
| DFUV · Dimensional ETF Trust | 0,14% | 60.086 NS | 31 Luglio 2026 | N-PORT |
| SUSL · iShares Trust | 0,14% | 4.238 SH | 11 Settembre 2026 | Giornaliero |
| FYEE · Fidelity Greenwood Street Trust | 0,14% | 839 NS | 31 Luglio 2026 | N-PORT |
| DSI · iShares Trust | 0,14% | 18.418 SH | 11 Settembre 2026 | Giornaliero |
| IQSU · New York Life Investments ETF Trust | 0,14% | 1.230 NS | 31 Luglio 2026 | N-PORT |
| CHRI · Global X Funds | 0,13% | 29 NS | 31 Luglio 2026 | N-PORT |
| VONV · VANGUARD SCOTTSDALE FUNDS | 0,13% | 72.504 SH | 19 Agosto 2026 | Giornaliero |
| IWD · iShares Trust | 0,13% | 267.199 SH | 11 Settembre 2026 | Giornaliero |
| BSCT · Invesco Exchange-Traded Self-Indexe… | 0,12% | 3.809.000 | 02 Ottobre 2026 | Giornaliero |
| NULV · Nushares ETF Trust | 0,11% | 6.797 NS | 31 Luglio 2026 | N-PORT |
| ESGU · iShares Trust | 0,11% | 47.962 SH | 11 Settembre 2026 | Giornaliero |
| DGRO · iShares Trust | 0,10% | 111.232 SH | 11 Settembre 2026 | Giornaliero |
| EGLE · Global X Funds | 0,10% | 6 NS | 31 Luglio 2026 | N-PORT |
| GLBL · Pacer Funds Trust | 0,10% | 3 NS | 31 Luglio 2026 | N-PORT |
| LQAI · Exchange Listed Funds Trust | 0,10% | 6 NS | 31 Luglio 2026 | N-PORT |
| EQAL · Invesco Exchange-Traded Fund Trust … | 0,09% | 1.886 SH | 02 Ottobre 2026 | Giornaliero |
| TOPC · iShares Trust | 0,09% | 72 SH | 11 Settembre 2026 | Giornaliero |
| ILCV · iShares Trust | 0,08% | 2.783 SH | 11 Settembre 2026 | Giornaliero |
| XVV · iShares Trust | 0,08% | 1.375 SH | 11 Settembre 2026 | Giornaliero |
| VV · VANGUARD INDEX FUNDS | 0,08% | 140.219 SH | 19 Agosto 2026 | Giornaliero |
| ESGV · VANGUARD WORLD FUND | 0,08% | 27.152 SH | 19 Agosto 2026 | Giornaliero |
| QVML · Invesco Exchange-Traded Fund Trust … | 0,08% | 3.447 SH | 02 Ottobre 2026 | Giornaliero |
| DFAC · Dimensional ETF Trust | 0,08% | 100.648 NS | 31 Luglio 2026 | N-PORT |
| XTR · Global X Funds | 0,08% | 10 NS | 31 Luglio 2026 | N-PORT |
| IVV · iShares Trust | 0,07% | 1.513.176 SH | 11 Settembre 2026 | Giornaliero |
| ILCB · iShares Trust | 0,07% | 2.328 SH | 11 Settembre 2026 | Giornaliero |
| XCLR · Global X Funds | 0,07% | 7 NS | 31 Luglio 2026 | N-PORT |
| VOO · VANGUARD INDEX FUNDS | 0,07% | 3.119.147 SH | 19 Agosto 2026 | Giornaliero |
| VTI · VANGUARD INDEX FUNDS | 0,07% | 3.812.375 SH | 19 Agosto 2026 | Giornaliero |
| VONE · VANGUARD SCOTTSDALE FUNDS | 0,07% | 19.809 SH | 19 Agosto 2026 | Giornaliero |
| VTHR · VANGUARD SCOTTSDALE FUNDS | 0,07% | 10.113 SH | 19 Agosto 2026 | Giornaliero |
| PBP · Invesco Exchange-Traded Fund Trust | 0,07% | 715 SH | 02 Ottobre 2026 | Giornaliero |
| PBUS · Invesco Exchange-Traded Fund Trust … | 0,07% | 20.848 SH | 02 Ottobre 2026 | Giornaliero |
| IYY · iShares Trust | 0,07% | 5.172 SH | 11 Settembre 2026 | Giornaliero |
| IWB · iShares Trust | 0,07% | 82.919 SH | 11 Settembre 2026 | Giornaliero |
| XYLD · Global X Funds | 0,07% | 6.091 NS | 31 Luglio 2026 | N-PORT |
| PTLC · Pacer Funds Trust | 0,07% | 6.112 NS | 31 Luglio 2026 | N-PORT |
| BBUS · J.P. Morgan Exchange-Traded Fund Tr… | 0,07% | 16.615 NS | 31 Luglio 2026 | N-PORT |
| USCL · iShares Trust | 0,07% | 4.768 SH | 11 Settembre 2026 | Giornaliero |
| VOTE · TCW ETF Trust | 0,07% | 2.035 NS | 31 Luglio 2026 | N-PORT |
| BKLC · BNY Mellon ETF Trust | 0,07% | 10.127 NS | 31 Luglio 2026 | N-PORT |
| XRMI · Global X Funds | 0,07% | 92 NS | 31 Luglio 2026 | N-PORT |
| IWV · iShares Trust | 0,07% | 33.101 SH | 11 Settembre 2026 | Giornaliero |
| ITOT · iShares Trust | 0,07% | 156.223 SH | 11 Settembre 2026 | Giornaliero |
| LRGF · iShares Trust | 0,06% | 5.842 SH | 11 Settembre 2026 | Giornaliero |
| DXUV · Dimensional ETF Trust | 0,06% | 959 NS | 31 Luglio 2026 | N-PORT |
| DFUS · Dimensional ETF Trust | 0,06% | 36.333 NS | 31 Luglio 2026 | N-PORT |
| XYLG · Global X Funds | 0,06% | 111 NS | 31 Luglio 2026 | N-PORT |
| SPUU · Direxion Shares ETF Trust | 0,06% | 453 NS | 31 Luglio 2026 | N-PORT |
| ILCG · iShares Trust | 0,06% | 4.804 SH | 11 Settembre 2026 | Giornaliero |
| QDPL · Pacer Funds Trust | 0,06% | 2.883 NS | 31 Luglio 2026 | N-PORT |
| TOV · EA Series Trust | 0,06% | 454 NS | 31 Luglio 2026 | N-PORT |
| TILT · FlexShares Trust | 0,06% | 3.564 NS | 31 Luglio 2026 | N-PORT |
| DFAU · Dimensional ETF Trust | 0,06% | 20.053 NS | 31 Luglio 2026 | N-PORT |
| PHDG · Invesco Actively Managed Exchange-T… | 0,06% | 95 SH | 02 Ottobre 2026 | Giornaliero |
| VOXP · Advisors Series Trust | 0,06% | 9 NS | 31 Luglio 2026 | N-PORT |
| TOK · iShares Trust | 0,06% | 333 SH | 11 Settembre 2026 | Giornaliero |
| HCMT · Direxion Shares ETF Trust | 0,05% | 835 NS | 31 Luglio 2026 | N-PORT |
| DCOR · Dimensional ETF Trust | 0,05% | 4.948 NS | 31 Luglio 2026 | N-PORT |
| URTH · iShares, Inc. | 0,05% | 10.772 SH | 11 Settembre 2026 | Giornaliero |
| SPXL · Direxion Shares ETF Trust | 0,05% | 9.382 NS | 31 Luglio 2026 | N-PORT |
| ACWI · iShares Trust | 0,05% | 38.539 SH | 11 Settembre 2026 | Giornaliero |
| VT · VANGUARD INTERNATIONAL EQUITY INDEX… | 0,04% | 196.805 SH | 19 Agosto 2026 | Giornaliero |
| OMFL · Invesco Exchange-Traded Self-Indexe… | 0,04% | 4.718 SH | 02 Ottobre 2026 | Giornaliero |
| NEAR · iShares U.S. ETF Trust | 0,03% | 1.504.000 SH | 11 Settembre 2026 | Giornaliero |
| GLOF · iShares Trust | 0,02% | 106 SH | 11 Settembre 2026 | Giornaliero |
| DYNF · BlackRock ETF Trust | 0,01% | 14.919 SH | 11 Settembre 2026 | Giornaliero |
| CRBN · iShares Trust | 0,01% | 383 SH | 11 Settembre 2026 | Giornaliero |
| VXUS · VANGUARD STAR FUNDS | 0,00% | 4.397.881 SH | 19 Agosto 2026 | Giornaliero |
| VPL · VANGUARD INTERNATIONAL EQUITY INDEX… | 0,00% | 401.850 SH | 19 Agosto 2026 | Giornaliero |
| VSS · VANGUARD INTERNATIONAL EQUITY INDEX… | 0,00% | 932.492 SH | 19 Agosto 2026 | Giornaliero |
| VEA · VANGUARD TAX-MANAGED FUNDS | 0,00% | 2.391.019 SH | 19 Agosto 2026 | Giornaliero |
| VSGX · VANGUARD WORLD FUND | 0,00% | 54.062 SH | 19 Agosto 2026 | Giornaliero |
| BIV · VANGUARD BOND INDEX FUNDS | · | · | 15 Luglio 2026 | Giornaliero |
| BLV · VANGUARD BOND INDEX FUNDS | · | · | 15 Luglio 2026 | Giornaliero |
| BSV · VANGUARD BOND INDEX FUNDS | · | · | 15 Luglio 2026 | Giornaliero |
| BND · VANGUARD BOND INDEX FUNDS | · | · | 15 Luglio 2026 | Giornaliero |
| VUSB · VANGUARD BOND INDEX FUNDS | · | · | 15 Luglio 2026 | Giornaliero |
| VPLS · VANGUARD MALVERN FUNDS | · | · | 15 Luglio 2026 | Giornaliero |
| VCSH · VANGUARD SCOTTSDALE FUNDS | · | · | 15 Luglio 2026 | Giornaliero |
| VCIT · VANGUARD SCOTTSDALE FUNDS | · | · | 15 Luglio 2026 | Giornaliero |
| VCLT · VANGUARD SCOTTSDALE FUNDS | · | · | 15 Luglio 2026 | Giornaliero |
| VTC · VANGUARD SCOTTSDALE FUNDS | · | · | 30 Luglio 2026 | Giornaliero |
| BNDW · VANGUARD SCOTTSDALE FUNDS | · | · | 30 Luglio 2026 | Giornaliero |
| VCEB · VANGUARD WORLD FUND | · | · | 30 Luglio 2026 | Giornaliero |
HUM Consenso degli analisti Opinioni degli analisti, sia rialziste che ribassiste, target price a 12 mesi, potenziale di rialzo
Target Price a 12 Mesi
23 analisti · 2026-09-30Target medio $423.74 +9,1%
Confronto Peer (GICS sub-settore industriale) Metriche chiave rispetto ai pari del settore
Base FY, prezzi alla chiusura dell'ultimo anno fiscale di ciascuna società.
| Ticker | Capitalizzazione di Mercato | P/E | Rev YoY | Margine Netto | ROE | Margine lordo |
|---|---|---|---|---|---|---|
| HUM | $50.90B | 26.0 | 10.1% | 0.92% | 7.0% | · |
| UNH | $299.08B | 25.0 | 11.8% | 2.7% | 12.0% | · |
| ELV | $77.37B | 13.9 | 12.5% | 2.8% | 13.3% | · |
| CNC | $20.24B | -3.0 | 19.4% | -3.4% | -28.8% | 7.3% |
| MOH | $8.85B | 19.5 | 11.8% | 1.0% | 10.9% | · |
| HQY | $7.12B | 34.0 | 9.5% | 16.4% | 10.1% | 69.5% |
| CLOV | · | -5.1 | 40.3% | -4.5% | -26.2% | · |
| PGNY | $2.14B | 39.5 | 10.4% | 4.5% | 11.3% | 23.6% |
| ALHC | $4.03B | · | 46.1% | -0.02% | -0.52% | · |
Ultime notizie Notizie recenti che menzionano questa società
Le Mie Metriche La tua watchlist personale — righe selezionate da Fondamentali Completi
Scegli le metriche che contano per te: fai clic sul + accanto a qualsiasi riga in Fondamentali Completi sopra.
La tua selezione è salvata e ti segue su tutti i ticker.